All Posts

Compounds able to reprogram insulin-resistant cells into a healthier state, with reduced side effects, are described in a new paper from Griffin lab.

“Major advances in science are usually launched by new methods and techniques…Happily, the history of biology teaches us that methods and techniques that today exist only in our imagination will materialize in some unexpected way.” Dr. Charles Weissmann, M.D., Ph.D. Dr. Charles Weissmann,…

An FDA‑approved medication called spironolactone, often prescribed as a diuretic, or water pill, for heart and blood pressure conditions, may be a useful add‑on to the standard HIV treatment, a new study shows.

Florida’s former CFO, Jeff Atwater, will chair the new Ambassador Council, joining Vice Chair Marti LaTour and nine other leaders in business, law, philanthropy, patient advocacy and more.

Mapping vulnerabilities in the SARS-CoV-2 genome, made of RNA, reveals a path to fighting more than COVID-19.

"These grants highlight The Wertheim UF Scripps Institute’s unique expertise in areas that include neuroscience, immunology, biochemistry, drug discovery and RNA therapeutics,” said Scientific Director Patrick Griffin, Ph.D.

The Wertheim UF Scripps Institute welcomes a new cohort of 10 graduate students to Jupiter, Florida, all pursuing their doctorates in the biomedical sciences.

Fifteen high school students from Palm Beach and Martin counties celebrated their summer of accomplishment at the Glenn W. Bailey STEM Education & Outreach Programs Kenan Fellows Summer Symposium.

Viruses infect cells with a goal of taking control to churn out new viral copies. Cells have learned to fight back.

A new study in Nature that finds a gene therapy against HIV given at birth can protect breastfeeding babies from infection with a single dose.